Acquiring provider of home sleep apnea diagnosis solutions will allow ZOLL to better serve undiagnosed and untreated cardiac patients CHELMSFORD, Mass. & CAESAREA, Israel–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Itamar™ Medical Ltd. (Nasdaq and TASE: ITMR), a medical device and […]
Tag: Itamar
Itamar Medical Appoints Marga Ortigas-Wedekind to its Board of Directors
CAESAREA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Marga Ortigas-Wedekind to its Board of Directors. Ms. Ortigas-Wedekind brings […]
Itamar Medical Reports Second Quarter 2021 Financial Results
– Revenues Increased 41% Year-over-Year to $12.6 Million – – U.S. WatchPATTM Revenues Increased 53% Year-over-Year to $10.1 Million – – Raised Full Year 2021 Revenue Guidance to a Range of $53 Million to $54 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT […]
Itamar Medical Appoints Brad Fluegel to its Board of Directors
CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Brad Fluegel to its Board of Directors. Mr. Fluegel’s vast […]
Itamar Medical Reports First Quarter 2021 Results
– First Quarter 2021 Revenues Increase 43% to $12.0 Million – – U.S. WatchPAT™ Revenues Increase 38% to $8.4 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT – CAESAREA, Israel, May 19, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and […]
Itamar Medical Reports Record Fourth Quarter and Full Year 2020 Revenues
– Record Fourth Quarter 2020 Revenues Increase 31% to $12.8 Million – – U.S. WatchPAT™ Revenues Increase 39% to $10.2 Million – – Full Year 2021 Revenue Guidance of $52 Million and $53 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT – CAESAREA, Israel, March 02, 2021 (GLOBE NEWSWIRE) […]
Itamar Medical Announces Closing of Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
CAESAREA, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its public […]
Itamar Medical Appoints Scott P. Serota to its Board of Directors
CAESAREA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Scott P. Serota to its Board of Directors. Mr. Serota’s […]
Itamar Medical Announces Preliminary Revenue Results for Fourth Quarter and Full Year 2020
– 2020 Fourth Quarter Revenues Expected to Increase More Than 28% to $12.5-$12.8 million – – 2020 Fiscal Year Revenues Expected to Increase Approximately 31% to $40.8-$41.1 million – CAESAREA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a leading medical device and digital health […]
Itamar Medical Announces Results from Multi-Center Study Validate Use of WatchPAT™ in Diagnosing Sleep Apnea in Patients with AFib
CAESAREA, Israel, Dec. 08, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company leading the integration of sleep apnea management into the cardiac patient care pathway, today announced the publication of a new study titled, ‘Watch-PAT is Useful in the Diagnosis of […]